Anna Streubel

Berlin, BE 14165, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.

Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.

Journal: Scientific reports

Published: January 11, 2024

Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies.

Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: May 22, 2023

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

Journal: International journal of molecular sciences

Published: September 01, 2022

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy.

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy.

Journal: BMC cancer

Published: February 24, 2021

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition.

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition.

Journal: Cancer management and research

Published: April 30, 2020

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing.

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing.

Journal: Oncotarget

Published: May 04, 2019

MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.

MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.

Journal: PloS one

Published: May 06, 2017

A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies.

A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies.

Journal: Leukemia

Published: April 22, 2015

Pathogenicity of Mycobacterium kansasii

Pathogenicity of Mycobacterium kansasii

Journal: Pneumologie (Stuttgart, Germany)

Published: July 22, 2014

A rare case of an EML4-ALK-rearranged lung adenocarcinoma missed by in situ-hybridization but detected by RT-PCR.

A rare case of an EML4-ALK-rearranged lung adenocarcinoma missed by in situ-hybridization but detected by RT-PCR.

Journal: Journal of clinical pathology

Published: July 17, 2014

The "COLD-PCR approach" for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer.

The "COLD-PCR approach" for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer.

Journal: Applied immunohistochemistry & molecular morphology : AIMM

Published: February 13, 2014

Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.

Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.

Journal: Journal of clinical pathology

Published: December 03, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026